Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 20:43 | 11/17/24 | ACAD | Health | Drug | Pharmaceutical Preparations | Teehan Brendan | CA | O | EVP,COO, | 2 | M.d | 174 | 5.76 | 0 | 30 | 94 | 62 | D | ||||||||||||||
11/19/24 20:43 | 11/19/24 | ACAD | Health | Drug | Pharmaceutical Preparations | Teehan Brendan | CA | O | EVP,COO, | 2 | S.d | -174 | 5.76 | 0 | -30 | 62 | D | |||||||||||||||
11/19/24 20:41 | 11/17/24 | ACAD | Health | Drug | Pharmaceutical Preparations | Kihara James | CA | O | PRINCIPA | 2 | M.d | 68 | 5.70 | 0 | 12 | 153 | 20 | D | ||||||||||||||
11/19/24 20:41 | 11/19/24 | ACAD | Health | Drug | Pharmaceutical Preparations | Kihara James | CA | O | PRINCIPA | 2 | S.d | -68 | 5.70 | 0 | -12 | 20 | D | |||||||||||||||
11/19/24 20:40 | 11/17/24 | ACAD | Health | Drug | Pharmaceutical Preparations | Schneyer Mark C. | CA | O | EVP,CFO | 2 | M.d | 172 | 5.73 | 0 | 30 | 130 | 53 | D | ||||||||||||||
11/19/24 20:40 | 11/19/24 | ACAD | Health | Drug | Pharmaceutical Preparations | Schneyer Mark C. | CA | O | EVP,CFO | 2 | S.d | -172 | 5.73 | 0 | -30 | 53 | D | |||||||||||||||
10/15/24 18:05 | 10/12/24 | ACAD | Health | Drug | Pharmaceutical Preparations | Ndu Adora | CA | D | 1 | M.d | 0 | 0.00 | 0 | 4 | 40 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |